Rush Presbyterian - Saint Luke's Med Ctr is a clinical research site located in Chicago, Illinois, United States 60612.
Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.
Rush Presbyterian - Saint Luke's Med Ctr has participated in 89 clinical trials with 1 currently active.
Therapeutic areas: Mycobacterium Avium-intracellulare Infection, HIV Infections, HIV Seronegativity.
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Hoffmann-La Roche, Amgen.
Trust Score: 90/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Rush Presbyterian - Saint Luke's Med Ctr has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rush Presbyterian - Saint Luke's Med Ctr has 89 clinical trials on record, with 1 currently active. Their work covers Mycobacterium Avium-intracellulare Infection, HIV Infections, HIV Seronegativity.
Yes — Rush Presbyterian - Saint Luke's Med Ctr holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.